Trials / Completed
CompletedNCT04373798
C-reactive Protein Levels Among Individuals With COVID-19
Triage Strategies Based on C-reactive Protein Levels Among Individuals With COVID-19: A Prospective Cohort Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,006 (actual)
- Sponsor
- Henning Bliddal · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this multi-center study is to clarify the value of a CRP measurement for triage of patients initially presenting with light symptoms of the COVID-19 infection. Current recommendations of management of COVID-19 include large-scale tests for virus. Such tests reveal whether an individual is infected with the virus, however, the demonstration of virus per se has no prognostic value for the ensuing course of the COVID-19 disease. Publications of possible treatments strategies increase exponentially, while evidence of triage of the affected individuals is mainly based on the level of pulmonary affection as measured by the Oxygen saturation. To inform decision making for which patients are to be hospitalized due to risk of developing more severe affection, this study addresses the question, whether triage may be performed with the aid of a simple CRP measurement.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | C-reactive protein | Measurement of CRP value from blood sample taken at covid19 check point (baseline). |
Timeline
- Start date
- 2020-05-04
- Primary completion
- 2020-08-30
- Completion
- 2021-03-30
- First posted
- 2020-05-04
- Last updated
- 2021-08-18
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT04373798. Inclusion in this directory is not an endorsement.